View : 95 Download: 0

Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease

Title
Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease
Authors
Jung, YoungaeLee, Min KyungPuri, PuneetKoo, Bo KyungJoo, Sae KyungJang, Seo YoungLee, Dong HyeonJung, Yong JinKim, Byeong GwanLee, Kook LaePark, Tae-SikKang, Ki-TaeRyu, Do HyunKang, Sang WonKim, DongheeOh, SoheeKim, WonHwang, Geum-Sook
Ewha Authors
강상원황금숙
SCOPUS Author ID
강상원scopus; 황금숙scopus
Issue Date
2020
Journal Title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ISSN
0269-2813JCR Link

1365-2036JCR Link
Citation
ALIMENTARY PHARMACOLOGY & THERAPEUTICS vol. 52, no. 10, pp. 1603 - 1614
Publisher
WILEY
Indexed
SCIE; SCOPUS WOS
Document Type
Article
Abstract
Background Non-alcoholic fatty liver disease (NAFLD) affects obese and non-obese individuals. However, mechanisms underlying non-obese non-alcoholic steatohepatitis (NASH) remain unclear. Aims To attempt to identify metabolic perturbations associated with non-obese and obese NAFLD using a lipidomics approach. Methods A cross-sectional analysis of 361 subjects with biopsy-proven NAFLD (157 NAFL and 138 NASH) and healthy controls (n = 66) was performed. Individuals were categorised as obese or non-obese based on the Asian cut-off for body mass index. Circulating lipidomic profiling of sera was performed based on the histological severity of NAFLD. Circulating lipidomic alterations were validated with an independent validation set (154 NAFLD subjects [93 NAFL and 61 NASH] and 21 healthy controls). Results Saturated sphingomyelin (SM) species were significantly associated with visceral adiposity in non-obese NAFLD (SM d38:0;P < 0.001) but not in obese NAFLD. Additionally, SM levels were significantly associated with systemic and adipose tissue insulin resistance (SM d38:0;P = 0.002 and <0.001, respectively). Five potential lipid metabolites for non-obese subjects and seven potential lipids for obese subjects were selected to predict NAFLD and NASH. These lipid combinations showed good diagnostic performance for non-obese (area under the curve [AUC] for NAFLD/NASH = 0.916/0.813) and obese (AUC for NAFLD/NASH = 0.967/0.812) subjects. Moreover, distinctly altered patterns of diacylglycerol (DAG), triacylglycerol (TAG) and SM levels were confirmed in the validation set depending on the histological severity of NAFLD. Conclusion Non-obese and obese NAFLD subjects exhibit unique circulating lipidomic signatures, including DAGs, TAGs and SMs. These lipid combinations may be useful biomarkers for non-obese and obese NAFLD patients.
Show the fulltext
DOI
10.1111/apt.16066
Appears in Collections:
자연과학대학 > 생명과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE